Gamma Secretase Inhibitors: Potentiating BCMA-Targeted Therapies
Time: 3:30 pm
day: Day Two
Details:
- Synergistic mechanism of action for gamma secretase inhibition on BCMA
applies to all BCMA-targeted therapy modalities - Sharing an open development approach by partnering across all BCMA modalities and also broadly within each modality
- GSI + BCMA combination synergy and potentiation as an example of translational medicine and precision medicine from proof-of-concept to validation with safety and efficacy evidence from clinical trials
